(Q35801421)

10 August 2017

1 reference

title

Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma (English)

1 reference

10 August 2017

1 reference

Kathleen Ververeli

1

1 reference

10 August 2017

Bradley Chipps

series ordinal

2

1 reference

10 August 2017

publication date

1 May 2004

1 reference

Annals of Allergy, Asthma & Immunology

10 August 2017

published in

1 reference

10 August 2017

volume

92

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

512-522

1 reference

Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Risk factors for age-related cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Corticosteroids in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Adverse effects of oral corticosteroids in relation to dose in patients with lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Steroid-dependent asthma treated with inhaled beclomethasone dipropionate. A long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Beclomethasone dipropionate aerosol in the treatment of steroid-dependent asthmatic patients. An assessment of 18 months of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

High-dose beclomethasone inhaler in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Treatment of Asthma with Triamcinolone Acetonide Aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Treatment of asthma in children with triamcinolone acetonide aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Multicenter study of flunisolide aerosol in adult patients with steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Short-term double-blind evaluation of flunisolide aerosol for steroid-dependent asthmatic children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

High dose inhaled budesonide in the treatment of severe steroid-dependent asthmatics. A two-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Nebulised budesonide in severe childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

High dose nebulized steroid in the treatment of chronic steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Long-term effects of budesonide or nedocromil in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

A double-blind, placebo-controlled steroid-sparing study with budesonide Turbuhaler in Japanese oral steroid-dependent asthma patients. Japanese Pulmicort Turbuhaler study group.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Beclomethasone dipropionate aerosol in the treatment of steroid-dependent asthma. A 12-week double-blind study comparing beclomethasone dipropionate and a vehicle aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Triamcinolone acetonide aerosols for asthma. I. Effective replacement of systemic corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

A short-term double-blind trial of aerosol triamcinolone acetonide in steroid-dependent patients with severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

A review of budesonide inhalation suspension in the treatment of pediatric asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Inhaled flunisolide for acute severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

A randomized, controlled trial of high dose, inhaled budesonide versus oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961758-9

7 January 2021

10.1016/S1081-1206(10)61758-9

Identifiers

DOI

1 reference

10 August 2017

1 reference